Approval · Notice of Compliance 37783 · 2026
EDARAVONE: Notice of Compliance 37783
Issued June 26, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37783
- Date
- June 26, 2026
- Company
- Shionogi Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EDARAVONE | 02569604 | Approved |
Medicinal ingredients
- EDARAVONE 105 MG per 5ML